Cargando…
Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG
The aberrant expression of the Tn antigen (CD175) on surface glycoproteins of human carcinomas is associated with tumorigenesis, metastasis, and poor survival. To target this antigen, we developed Remab6, a recombinant, human chimeric anti-Tn-specific monoclonal IgG. However, this antibody lacks ant...
Autores principales: | Matsumoto, Yasuyuki, Jia, Nan, Heimburg-Molinaro, Jamie, Cummings, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050417/ https://www.ncbi.nlm.nih.gov/pubmed/36977722 http://dx.doi.org/10.1038/s41598-023-31195-6 |
Ejemplares similares
-
Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions
por: Dombek, Gabrielle E., et al.
Publicado: (2022) -
Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
por: Gupta, Aaron, et al.
Publicado: (2023) -
A functional spleen contributes to afucosylated IgG in humans
por: Wojcik, Iwona, et al.
Publicado: (2021) -
The Relation of the Level of Serum Anti-TF, -Tn and -Alpha-Gal IgG to Survival in Gastrointestinal Cancer Patients
por: Smorodin, Eugeniy, et al.
Publicado: (2013) -
Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice
por: Braster, Rens, et al.
Publicado: (2021)